Covid Pill

 Washington Post: Merck’s experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports The clinical trial is being stopped early, and the drug-maker plans to apply for emergency authorization as soon as possible By Carolyn Y. Johnson

Merck and partner Ridgeback Biotherapeutics said in a news release they would apply for emergency use authorization for the drug, molnupiravir, in the United States as soon as possible. It would be the first antiviral pill for covid-19.